Physician profile
Michael Q Luu
NPI 1578520763
$6,238.64
in general payments reported to CMS, 2019-2025
32 companies · $648 in 2025
The $648 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,546 · 2020: $755 · 2021: $985 · 2022: $1,080 · 2023: $811 · 2024: $414 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,370.85 | 2019-2025 | |
| Pfizer INC. | $802.47 | 2019-2025 | |
| Amgen INC. | $796.75 | 2019-2025 | Repatha |
| Actelion Pharmaceuticals US, INC. | $703.93 | 2019-2025 | Uptravi, Opsumit |
| Boston Scientific Corporation | $565.81 | 2020-2023 | Emblem Mri S-Icd |
| Abbott Laboratories | $249.40 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.67 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $161.02 | 2019-2024 | Camzyos |
| Medtronic Vascular, INC. | $144.49 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $142.50 | 2023 | Duobrii, Siliq |
| Janssen Pharmaceuticals, INC | $140.83 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $130.87 | 2022-2025 | Assure Wcd |
| Amarin Pharma, INC. | $112.88 | 2019 | |
| Novo Nordisk INC | $107.15 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $83.32 | 2021-2025 | Verquvo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $81.81 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.28 | 2019 | |
| Cleerly, INC. | $63.63 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Gilead Sciences, INC. | $39.76 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $35.87 | 2022 | |
| Esperion Therapeutics, INC. | $29.75 | 2024 | Nexletol |
| Edwards Lifesciences Corporation | $28.38 | 2019 | |
| Sobi, INC | $24.02 | 2022 | |
| Alnylam Pharmaceuticals INC. | $21.53 | 2019 | |
| Irhythm Technologies, INC. | $20.91 | 2023 | Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $18.54 | 2019 | |
| Mannkind Corporation | $17.97 | 2023 | Afrezza |
| Akcea Therapeutics, INC. | $16.40 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.23 | 2019 | |
| Pulmonx Corporation | $15.80 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Atricure, INC. | $15.66 | 2021 | |
| Tactile Systems Technology INC | $14.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Luu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.